As the results of the SBAC Common Core testing across the nation are made public, the backlash from parents could possibly be severe and felt in every state as well as by the Department of Education ...
Clinical Genomics has launched a blood-based test for monitoring colorectal cancer recurrence called Colvera, the company announced. “Current professional guidelines recommend inclusion of the ...
Results underscore clinical utility of novel circulating tumor DNA assay to detect disease recurrence Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, ...
PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, announced the launch of a new, patent-pending, customized test to accurately measure ...
Assessing Surveillance Utilization and Value in Commercially Insured Patients With Colorectal Cancer
Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but ...
LONDON, June 29, 2017 /PRNewswire/ -- The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover ...
These markers are most helpful when someone already has a diagnosed cancer — to track treatment response or detect recurrence ...
Retrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States. Background: Relapse after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback